APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oligonucleotide Pool Library

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

Selected research

Market Outlook & Growth Opportunities

Global Oligonucleotide Pool Library Market Outlook and Growth Opportunities 2026

26 December 2025198 pages

Choose your research edition.

Industry ResearchOligonucleotide Pool Library Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oligonucleotide Pool Library Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Oligonucleotide Pool Library Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oligonucleotide Pool Library Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oligonucleotide Pool Library Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, had a more than 40% combined market share.

North America occupied the largest market share with about 40%. It was followed by Europe，with 30%. Integrated DNA Technologies, Illumnia, Agilent, Sigma-aldrich and Eurofins Genomics are the top 5 manufacturers of global Oligonucleotide Pool Library market, and they had a more than 40% combined market share.

This report provides an overview of the global Oligonucleotide Pool Library market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Oligonucleotide Pool Library and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oligonucleotide Pool Library revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Oligonucleotide Pool Library market.

Oligonucleotide Pool Library Segment by Company

Agilent

Eurogentec S.A

Sigmaaldrich

Illumnia

L.G.C Biosearch Technologies

Eurofins Genomics

Roche NimbleGe

Integrated DNA Technologies

Nitto Denko Avecia Inc

General Biosystems

MYcroarray

Twist Bioscience

CustomArray

LC Sciences

Creative Biogene

Oligonucleotide Pool Library Segment by Type

DNA Oligos

RNA Oligos

Oligonucleotide Pool Library Segment by Application

Target Capture

CRISPR/Cas9 Designs

Gene Synthesis

Library Preparation

Others

Oligonucleotide Pool Library Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oligonucleotide Pool Library status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oligonucleotide Pool Library key companies, revenue, market share, and recent developments.

3. To split the Oligonucleotide Pool Library breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oligonucleotide Pool Library market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oligonucleotide Pool Library significant trends, drivers, influence factors in global and regions.

6. To analyze Oligonucleotide Pool Library competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Pool Library market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Pool Library and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Pool Library.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oligonucleotide Pool Library industry.

Chapter 3: Detailed analysis of Oligonucleotide Pool Library company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oligonucleotide Pool Library in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oligonucleotide Pool Library in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oligonucleotide Pool Library Industry Trends Table 2. Oligonucleotide Pool Library Industry Drivers Table 3. Oligonucleotide Pool Library Industry Opportunities and Challenges Table 4. Oligonucleotide Pool Library Industry Restraints Table 5. Global Oligonucleotide Pool Library Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oligonucleotide Pool Library Revenue Share by Company (2021-2026) Table 7. Global Oligonucleotide Pool Library Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Oligonucleotide Pool Library Key Company Manufacturing Base & Headquarters Table 9. Global Oligonucleotide Pool Library Company, Product Type & Application Table 10. Global Oligonucleotide Pool Library Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Oligonucleotide Pool Library by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of DNA Oligos Table 15. Significant Companies of RNA Oligos Table 16. Global Oligonucleotide Pool Library Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Oligonucleotide Pool Library Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Oligonucleotide Pool Library Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Oligonucleotide Pool Library Sales Value Share by Type (2021-2026) Table 20. Global Oligonucleotide Pool Library Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Target Capture Table 22. Significant Companies of CRISPR/Cas9 Designs Table 23. Significant Companies of Gene Synthesis Table 24. Significant Companies of Library Preparation Table 25. Significant Companies of Others Table 26. Global Oligonucleotide Pool Library Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oligonucleotide Pool Library Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Oligonucleotide Pool Library Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Oligonucleotide Pool Library Sales Value Share by Application (2021-2026) Table 30. Global Oligonucleotide Pool Library Sales Value Share by Application (2027-2032) Table 31. Global Oligonucleotide Pool Library Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Oligonucleotide Pool Library Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Oligonucleotide Pool Library Sales Value Share by Region (2021-2026) Table 34. Global Oligonucleotide Pool Library Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Oligonucleotide Pool Library Sales Value Share by Region (2027-2032) Table 36. Global Oligonucleotide Pool Library Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oligonucleotide Pool Library Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Oligonucleotide Pool Library Sales Value Market Share by Country (2021-2026) Table 39. Global Oligonucleotide Pool Library Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Oligonucleotide Pool Library Sales Value Market Share by Country (2027-2032) Table 41. Agilent Company Information Table 42. Agilent Business Overview Table 43. Agilent Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Agilent Oligonucleotide Pool Library Product Portfolio Table 45. Agilent Recent Development Table 46. Eurogentec S.A Company Information Table 47. Eurogentec S.A Business Overview Table 48. Eurogentec S.A Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Eurogentec S.A Oligonucleotide Pool Library Product Portfolio Table 50. Eurogentec S.A Recent Development Table 51. Sigmaaldrich Company Information Table 52. Sigmaaldrich Business Overview Table 53. Sigmaaldrich Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Sigmaaldrich Oligonucleotide Pool Library Product Portfolio Table 55. Sigmaaldrich Recent Development Table 56. Illumnia Company Information Table 57. Illumnia Business Overview Table 58. Illumnia Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Illumnia Oligonucleotide Pool Library Product Portfolio Table 60. Illumnia Recent Development Table 61. L.G.C Biosearch Technologies Company Information Table 62. L.G.C Biosearch Technologies Business Overview Table 63. L.G.C Biosearch Technologies Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. L.G.C Biosearch Technologies Oligonucleotide Pool Library Product Portfolio Table 65. L.G.C Biosearch Technologies Recent Development Table 66. Eurofins Genomics Company Information Table 67. Eurofins Genomics Business Overview Table 68. Eurofins Genomics Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Eurofins Genomics Oligonucleotide Pool Library Product Portfolio Table 70. Eurofins Genomics Recent Development Table 71. Roche NimbleGe Company Information Table 72. Roche NimbleGe Business Overview Table 73. Roche NimbleGe Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Roche NimbleGe Oligonucleotide Pool Library Product Portfolio Table 75. Roche NimbleGe Recent Development Table 76. Integrated DNA Technologies Company Information Table 77. Integrated DNA Technologies Business Overview Table 78. Integrated DNA Technologies Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Integrated DNA Technologies Oligonucleotide Pool Library Product Portfolio Table 80. Integrated DNA Technologies Recent Development Table 81. Nitto Denko Avecia Inc Company Information Table 82. Nitto Denko Avecia Inc Business Overview Table 83. Nitto Denko Avecia Inc Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Nitto Denko Avecia Inc Oligonucleotide Pool Library Product Portfolio Table 85. Nitto Denko Avecia Inc Recent Development Table 86. General Biosystems Company Information Table 87. General Biosystems Business Overview Table 88. General Biosystems Oligonucleotide Pool Library Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. General Biosystems Oligonucleotide Pool Library Product Portfolio Table 90. General Biosystems Recent Development Table 91. MYcroarray Company Information Table 92. MYcroarray Business Overview Table 93. MYcroarray Oligonucleotide Pool Library Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. MYcroarray Oligonucleotide Pool Library Product Portfolio Table 95. MYcroarray Recent Development Table 96. Twist Bioscience Company Information Table 97. Twist Bioscience Business Overview Table 98. Twist Bioscience Oligonucleotide Pool Library Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Twist Bioscience Oligonucleotide Pool Library Product Portfolio Table 100. Twist Bioscience Recent Development Table 101. CustomArray Company Information Table 102. CustomArray Business Overview Table 103. CustomArray Oligonucleotide Pool Library Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. CustomArray Oligonucleotide Pool Library Product Portfolio Table 105. CustomArray Recent Development Table 106. LC Sciences Company Information Table 107. LC Sciences Business Overview Table 108. LC Sciences Oligonucleotide Pool Library Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. LC Sciences Oligonucleotide Pool Library Product Portfolio Table 110. LC Sciences Recent Development Table 111. Creative Biogene Company Information Table 112. Creative Biogene Business Overview Table 113. Creative Biogene Oligonucleotide Pool Library Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Creative Biogene Oligonucleotide Pool Library Product Portfolio Table 115. Creative Biogene Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Oligonucleotide Pool Library Product Image Figure 2. Global Oligonucleotide Pool Library Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oligonucleotide Pool Library Market Size (2021-2032) & (US$ Million) Figure 4. Global Oligonucleotide Pool Library Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. DNA Oligos Image Figure 8. RNA Oligos Image Figure 9. Global Oligonucleotide Pool Library Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Oligonucleotide Pool Library Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Oligonucleotide Pool Library Sales Value Share by Type (2021-2032) Figure 12. Target Capture Image Figure 13. CRISPR/Cas9 Designs Image Figure 14. Gene Synthesis Image Figure 15. Library Preparation Image Figure 16. Others Image Figure 17. Global Oligonucleotide Pool Library Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Oligonucleotide Pool Library Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Oligonucleotide Pool Library Sales Value Share by Application (2021-2032) Figure 20. Global Oligonucleotide Pool Library Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Oligonucleotide Pool Library Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Oligonucleotide Pool Library Sales Value (2021-2032) & (US$ Million) Figure 23. North America Oligonucleotide Pool Library Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Oligonucleotide Pool Library Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Oligonucleotide Pool Library Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Oligonucleotide Pool Library Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Oligonucleotide Pool Library Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Oligonucleotide Pool Library Sales Value (2021-2032) & (US$ Million) Figure 29. South America Oligonucleotide Pool Library Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Oligonucleotide Pool Library Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Oligonucleotide Pool Library Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Oligos
  • RNA Oligos
Applications
  • Target Capture
  • CRISPR/Cas9 Designs
  • Gene Synthesis
  • Library Preparation
  • Others
Companies covered
  • Agilent
  • Eurogentec S.A
  • Sigmaaldrich
  • Illumnia
  • L.G.C Biosearch Technologies
  • Eurofins Genomics
  • Roche NimbleGe
  • Integrated DNA Technologies
  • Nitto Denko Avecia Inc
  • General Biosystems
  • MYcroarray
  • Twist Bioscience
  • CustomArray
  • LC Sciences
  • Creative Biogene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oligonucleotide Pool Library Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oligonucleotide Pool Library Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Oligonucleotide Pool Library Market Dynamics
  1. 2.1 Oligonucleotide Pool Library Industry Trends
  2. 2.2 Oligonucleotide Pool Library Industry Drivers
  3. 2.3 Oligonucleotide Pool Library Industry Opportunities and Challenges
  4. 2.4 Oligonucleotide Pool Library Industry Restraints
3 Oligonucleotide Pool Library Market by Company
  1. 3.1 Global Oligonucleotide Pool Library Company Revenue Ranking in 2025
  2. 3.2 Global Oligonucleotide Pool Library Revenue by Company (2021-2026)
  3. 3.3 Global Oligonucleotide Pool Library Company Ranking (2024-2026)
  4. 3.4 Global Oligonucleotide Pool Library Company Manufacturing Base and Headquarters
  5. 3.5 Global Oligonucleotide Pool Library Company Product Type and Application
  6. 3.6 Global Oligonucleotide Pool Library Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Oligonucleotide Pool Library Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Oligonucleotide Pool Library Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Oligonucleotide Pool Library Market by Type
  1. 4.1 Oligonucleotide Pool Library Type Introduction
  2. 4.1.1 DNA Oligos
  3. 4.1.2 RNA Oligos
  4. 4.2 Global Oligonucleotide Pool Library Sales Value by Type
  5. 4.2.1 Global Oligonucleotide Pool Library Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oligonucleotide Pool Library Sales Value by Type (2021-2032)
  7. 4.2.3 Global Oligonucleotide Pool Library Sales Value Share by Type (2021-2032)
5 Oligonucleotide Pool Library Market by Application
  1. 5.1 Oligonucleotide Pool Library Application Introduction
  2. 5.1.1 Target Capture
  3. 5.1.2 CRISPR/Cas9 Designs
  4. 5.1.3 Gene Synthesis
  5. 5.1.4 Library Preparation
  6. 5.1.5 Others
  7. 5.2 Global Oligonucleotide Pool Library Sales Value by Application
  8. 5.2.1 Global Oligonucleotide Pool Library Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Oligonucleotide Pool Library Sales Value by Application (2021-2032)
  10. 5.2.3 Global Oligonucleotide Pool Library Sales Value Share by Application (2021-2032)
6 Oligonucleotide Pool Library Regional Value Analysis
  1. 6.1 Global Oligonucleotide Pool Library Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oligonucleotide Pool Library Sales Value by Region (2021-2032)
  3. 6.2.1 Global Oligonucleotide Pool Library Sales Value by Region: 2021-2026
  4. 6.2.2 Global Oligonucleotide Pool Library Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oligonucleotide Pool Library Sales Value (2021-2032)
  7. 6.3.2 North America Oligonucleotide Pool Library Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Oligonucleotide Pool Library Sales Value (2021-2032)
  10. 6.4.2 Europe Oligonucleotide Pool Library Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Oligonucleotide Pool Library Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Oligonucleotide Pool Library Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Oligonucleotide Pool Library Sales Value (2021-2032)
  16. 6.6.2 South America Oligonucleotide Pool Library Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Oligonucleotide Pool Library Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Oligonucleotide Pool Library Sales Value Share by Country, 2025 VS 2032
7 Oligonucleotide Pool Library Country-level Value Analysis
  1. 7.1 Global Oligonucleotide Pool Library Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oligonucleotide Pool Library Sales Value by Country (2021-2032)
  3. 7.2.1 Global Oligonucleotide Pool Library Sales Value by Country (2021-2026)
  4. 7.2.2 Global Oligonucleotide Pool Library Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Oligonucleotide Pool Library Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Oligonucleotide Pool Library Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Oligonucleotide Pool Library Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent
  2. 8.1.1 Agilent Company Information
  3. 8.1.2 Agilent Business Overview
  4. 8.1.3 Agilent Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Oligonucleotide Pool Library Product Portfolio
  6. 8.1.5 Agilent Recent Developments
  7. 8.2 Eurogentec S.A
  8. 8.2.1 Eurogentec S.A Company Information
  9. 8.2.2 Eurogentec S.A Business Overview
  10. 8.2.3 Eurogentec S.A Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurogentec S.A Oligonucleotide Pool Library Product Portfolio
  12. 8.2.5 Eurogentec S.A Recent Developments
  13. 8.3 Sigmaaldrich
  14. 8.3.1 Sigmaaldrich Company Information
  15. 8.3.2 Sigmaaldrich Business Overview
  16. 8.3.3 Sigmaaldrich Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sigmaaldrich Oligonucleotide Pool Library Product Portfolio
  18. 8.3.5 Sigmaaldrich Recent Developments
  19. 8.4 Illumnia
  20. 8.4.1 Illumnia Company Information
  21. 8.4.2 Illumnia Business Overview
  22. 8.4.3 Illumnia Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumnia Oligonucleotide Pool Library Product Portfolio
  24. 8.4.5 Illumnia Recent Developments
  25. 8.5 L.G.C Biosearch Technologies
  26. 8.5.1 L.G.C Biosearch Technologies Company Information
  27. 8.5.2 L.G.C Biosearch Technologies Business Overview
  28. 8.5.3 L.G.C Biosearch Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  29. 8.5.4 L.G.C Biosearch Technologies Oligonucleotide Pool Library Product Portfolio
  30. 8.5.5 L.G.C Biosearch Technologies Recent Developments
  31. 8.6 Eurofins Genomics
  32. 8.6.1 Eurofins Genomics Company Information
  33. 8.6.2 Eurofins Genomics Business Overview
  34. 8.6.3 Eurofins Genomics Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurofins Genomics Oligonucleotide Pool Library Product Portfolio
  36. 8.6.5 Eurofins Genomics Recent Developments
  37. 8.7 Roche NimbleGe
  38. 8.7.1 Roche NimbleGe Company Information
  39. 8.7.2 Roche NimbleGe Business Overview
  40. 8.7.3 Roche NimbleGe Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Roche NimbleGe Oligonucleotide Pool Library Product Portfolio
  42. 8.7.5 Roche NimbleGe Recent Developments
  43. 8.8 Integrated DNA Technologies
  44. 8.8.1 Integrated DNA Technologies Company Information
  45. 8.8.2 Integrated DNA Technologies Business Overview
  46. 8.8.3 Integrated DNA Technologies Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Integrated DNA Technologies Oligonucleotide Pool Library Product Portfolio
  48. 8.8.5 Integrated DNA Technologies Recent Developments
  49. 8.9 Nitto Denko Avecia Inc
  50. 8.9.1 Nitto Denko Avecia Inc Company Information
  51. 8.9.2 Nitto Denko Avecia Inc Business Overview
  52. 8.9.3 Nitto Denko Avecia Inc Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nitto Denko Avecia Inc Oligonucleotide Pool Library Product Portfolio
  54. 8.9.5 Nitto Denko Avecia Inc Recent Developments
  55. 8.10 General Biosystems
  56. 8.10.1 General Biosystems Company Information
  57. 8.10.2 General Biosystems Business Overview
  58. 8.10.3 General Biosystems Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  59. 8.10.4 General Biosystems Oligonucleotide Pool Library Product Portfolio
  60. 8.10.5 General Biosystems Recent Developments
  61. 8.11 MYcroarray
  62. 8.11.1 MYcroarray Company Information
  63. 8.11.2 MYcroarray Business Overview
  64. 8.11.3 MYcroarray Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MYcroarray Oligonucleotide Pool Library Product Portfolio
  66. 8.11.5 MYcroarray Recent Developments
  67. 8.12 Twist Bioscience
  68. 8.12.1 Twist Bioscience Company Information
  69. 8.12.2 Twist Bioscience Business Overview
  70. 8.12.3 Twist Bioscience Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Twist Bioscience Oligonucleotide Pool Library Product Portfolio
  72. 8.12.5 Twist Bioscience Recent Developments
  73. 8.13 CustomArray
  74. 8.13.1 CustomArray Company Information
  75. 8.13.2 CustomArray Business Overview
  76. 8.13.3 CustomArray Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CustomArray Oligonucleotide Pool Library Product Portfolio
  78. 8.13.5 CustomArray Recent Developments
  79. 8.14 LC Sciences
  80. 8.14.1 LC Sciences Company Information
  81. 8.14.2 LC Sciences Business Overview
  82. 8.14.3 LC Sciences Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LC Sciences Oligonucleotide Pool Library Product Portfolio
  84. 8.14.5 LC Sciences Recent Developments
  85. 8.15 Creative Biogene
  86. 8.15.1 Creative Biogene Company Information
  87. 8.15.2 Creative Biogene Business Overview
  88. 8.15.3 Creative Biogene Oligonucleotide Pool Library Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Creative Biogene Oligonucleotide Pool Library Product Portfolio
  90. 8.15.5 Creative Biogene Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst